Arthritis, Gouty

7 registered clinical trials studyying Arthritis, Gouty.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) NCT06846515	Arthrosi Therapeutics	Phase 3
Active Not Recruiting	Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) NCT06439602	Arthrosi Therapeutics	Phase 3
Unknown	The MAD Study of SSGJ-613 in Healthy Subjects NCT05966701	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.	Phase 1
Completed	Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Topha NCT05253833	Arthrosi Therapeutics	Phase 2
Completed	Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients NCT05119686	Arthrosi Therapeutics	Phase 2
Completed	Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout NCT00663169	Novartis	Phase 2
Completed	Celebrex In Acute Gouty Arthritis Study NCT00549549	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3